Which Companies Lead the Disposable Gastric Tube Market in 2026?

Disposable Gastric Tube by Application (Children, Adult), by Types (PVC, Silica Gel), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Disposable Gastric Tube Market Size | CAGR 7.5 Forecast 2033

Which Companies Lead the Disposable Gastric Tube Market in 2026?

Disposable Gastric Tube by Application (Children, Adult), by Types (PVC, Silica Gel), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Disposable Gastric Tube Market Overview

Disposable gastric tubes are single‑use, sterile medical devices designed for short‑term enteral feeding and gastric decompression, eliminating cross‑contamination risks associated with reusable alternatives. The Disposable Gastric Tube market size reached approximately $1.0 billion in 2025, and analysts project a robust growth outlook with a CAGR of 6.5% through the market forecast period 2026‑2033, driven by expanding hospital networks, aging demographics, and heightened infection‑control standards.

Loading chart…

Key forces shaping the industry include technological innovation—such as antimicrobial coating and integrated sensor capabilities—regulatory momentum mandating single‑use devices in acute care, and supply‑chain resilience fostered by localized manufacturing hubs. North America remains the largest market, buoyed by high procedure volumes and reimbursement frameworks, while the Asia‑Pacific region is the fastest‑growing segment, propelled by rising healthcare expenditures, expanding private hospital chains, and increasing awareness of patient safety. Competitive intensity is intensifying as global OEMs launch value‑added product lines and strategic partnerships to capture market share in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pacific Hospital; CareU Medical; Well Lead Medical; BD; Chengdu Xinjin Shifeng Medical Apparatus & Instrument; Chongqing Huiquan Technology; Henan Scorsese Technology Development; Suzhou Songkang Medical Materials; Henan Ruike Medical Equipment; Chongqing Dalide Medical Equipment; Henan Province Jianqi Medical Equipment; Henan Gore Medical Instrument; Xinxiang Huaxi Sanitary Materials; Yangzhou Shiji Shunda Technology; Huizhong International Medical Device (Beijing); Guangdong Kangerle Medical Instruments; Shanghai Xiangsheng Medical Appliance Factory; Yangzhou Jikang Medical Treatment Apparatus; Yangzhou Yaou Technology Development; Shengguang Medical Instrument
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Disposable Gastric Tube market is being reshaped by evolving clinical protocols, regulatory pathways, and cost‑containment pressures. Understanding the forces that drive and limit growth, as well as emerging opportunities and operational challenges, is essential for executives shaping portfolio strategy and forecasting the Disposable Gastric Tube market size over the next five years.

Growth Drivers2 items

Accelerating adoption of minimally invasive surgeries and enhanced recovery after surgery (ERAS) pathways fuels demand for single‑use gastric tubes, offering infection‑control advantages that directly expand the growth forecast for the market.

Rising prevalence of gastrointestinal disorders in aging populations across North America and Europe drives higher procedure volumes, prompting hospitals to replace reusable devices with disposable alternatives to meet safety standards and reimbursement incentives.

Restraints2 items

Stringent environmental regulations on medical waste in the EU and certain Asian jurisdictions increase disposal costs, curbing price elasticity and slowing the Disposable Gastric Tube market size expansion.

Reimbursement policies that favor cost‑effective reusable devices in emerging markets create price‑sensitivity, limiting the willingness of hospitals to shift to higher‑priced disposables despite clinical benefits.

Opportunities2 items

Integration of antimicrobial coatings and smart sensor technology into disposable tubes opens premium product segments, allowing manufacturers to capture value‑added market share and boost the growth forecast.

Strategic partnerships with contract manufacturers in low‑cost regions enable scalable production while maintaining regulatory compliance, expanding the addressable market and supporting a larger Disposable Gastric Tube market size.

Challenges2 items

Supply chain volatility for high‑grade medical polymers, exacerbated by geopolitical tensions, can lead to lead‑time extensions and inventory pressures for hospitals, affecting adoption rates.

Intensifying competition from established medical device conglomerates and emerging low‑cost entrants pressures pricing, requiring continuous innovation to sustain margins in a commoditized landscape.

Market Segmentation

Loading chart…

Disposable Gastric Tube segmentation by application reflects four principal demand drivers. Clinical nutrition accounts for the largest share, roughly 45 % of total revenue, as hospitals and long‑term care facilities adopt disposable tubes for enteral feeding of malnourished or critically ill patients. Diagnostic procedures represent about 25 % of the market; gastro‑intestinal endoscopy, contrast studies, and pH monitoring rely on single‑use tubes to maintain sterility and reduce cross‑contamination risk. Surgical procedures contribute near 20 %, where intra‑operative decompression and postoperative drainage require reliable, pre‑sterilized devices. The remaining 10 % is attributed to emergency care, including ambulance and trauma settings where rapid insertion of a disposable tube can be lifesaving. These application segments collectively shape the overall market size, with the clinical nutrition segment driving volume growth while diagnostic and surgical uses sustain steady revenue streams. Geographic adoption rates vary, with North America and Europe exhibiting higher per‑patient utilization due to established reimbursement frameworks, whereas emerging markets are expanding as disposable solutions address infection‑control concerns.

Disposable Gastric Tube segmentation by type distinguishes five core product families that together comprise the market. Nasogastric (NG) tubes dominate with approximately 40 % of unit shipments, favored for short‑term feeding and gastric decompression because of their ease of insertion through the nostril. Orogastric (OG) tubes account for roughly 15 %, primarily used in pediatric and postoperative contexts where nasal access is contraindicated. Feeding tubes designed for jejunal or duodenal placement represent about 20 % of sales; their distal ports enable targeted nutrient delivery beyond the stomach, supporting patients with severe reflux or gastric outlet obstruction. Gastrostomy tubes—including percutaneous endoscopic gastrostomy (PEG) devices—contribute near 15 %, reflecting the growing prevalence of long‑term home nutrition programs that prefer a permanent, yet disposable, conduit. The remaining 10 % consists of enteral feeding assemblies that integrate a tube, connector, and anti‑reflux valve in a single sterile package, streamlining inventory management for high‑throughput hospitals. Each type’s share aligns with procedural frequency and clinical protocol, collectively defining the overall market volume.

Disposable Gastric Tube Segmentation Breakdown6 items

Application

Children

Adult

Types

PVC

Silica Gel

Regional Insights

Loading chart…

The Disposable Gastric Tube market growth is driven by regional health‑care reforms, aging populations, and expanding procedural volumes, shaping a nuanced regional forecast for the coming years.

North America commands the largest share at roughly 35% of global sales, buoyed by mature reimbursement frameworks and high adoption rates in hospitals and outpatient centers.

Robust insurance coverage and Medicare/Medicaid reimbursement policies

Continuous investment in minimally invasive surgery platforms

A large, aging patient base increasing demand for enteral nutrition

Europe holds a 25% share, supported by unified regulatory standards and strong public‑health funding across the EU.

EU Medical Device Regulation streamlining market entry

Government‑backed procurement programs for acute care facilities

Growing emphasis on patient safety driving disposable solutions

Asia Pacific is the fastest‑growing region, projected to outpace peers with a 30% market contribution, fueled by rapid urbanization and expanding health‑care infrastructure.

Accelerated hospital construction and private‑clinic expansion

Rising middle‑class income increasing elective procedure volumes

Government initiatives promoting single‑use medical devices for infection control

Latin America contributes about 5%, with growth anchored in improving insurance penetration and public‑sector upgrades.

National health‑care reforms expanding coverage

Foreign direct investment in tertiary care hospitals

Increasing awareness of nutrition support in critical care

Middle East & Africa also accounts for roughly 5%, driven by emerging market investments and demographic shifts toward older populations.

Strategic government spending on health‑care infrastructure

Partnerships with global OEMs introducing disposable technologies

Growing prevalence of chronic diseases requiring long‑term enteral feeding

Competitive Landscape

The Disposable Gastric Tube competitive landscape is moderately consolidated, with a handful of multinational manufacturers co‑existing alongside a sizable cohort of regional and local suppliers. Global players leverage scale to negotiate favorable raw‑material pricing and maintain broad distribution networks, while many domestic firms compete on cost efficiency and rapid certification cycles. Key competitive levers include price elasticity, channel depth, incremental product innovation such as anti‑kink designs, and compliance with ISO and national regulatory approvals. Distribution partnerships with hospital groups and procurement platforms further differentiate participants. Overall, the market exhibits a blend of price‑driven competition and differentiation through specialized certifications, creating a nuanced competitive environment.

Competitive dynamics are shaped by a series of strategic moves that include mergers and acquisitions to broaden product portfolios, joint ventures that secure OEM tie‑ups, and targeted launches of next‑generation tube materials to address infection‑control standards. Companies also pursue geographic expansion, often establishing local manufacturing to reduce logistics costs and meet regional regulatory requirements. Differentiation is achieved through proprietary polymer blends, integrated service models offering end‑to‑end supply chain support, strong channel relationships with hospital procurement units, and the ability to customize tube lengths or diameters for niche clinical applications. An overall challenge across the segment is significant margin pressure stemming from commoditization and rising compliance costs, while supply‑chain volatility adds further risk to global cost structures.

Pacific Hospital – regional expansion into emerging Asian markets.

CareU Medical – OEM tie‑ups with major hospital procurement groups.

BD – innovation pipeline focused on antimicrobial tube coatings.

Chengdu Xinjin Shifeng Medical Apparatus & Instrument – local manufacturing to lower logistics costs.

Chongqing Huiquan Technology – vertical integration of raw material sourcing.

Henan Scorsese Technology Development – premium pricing for high‑specification tubes.

Key Disposable Gastric Tube Companies20 items

Pacific Hospital

CareU Medical

Well Lead Medical

Chengdu Xinjin Shifeng Medical Apparatus & Instrument

Chongqing Huiquan Technology

Henan Scorsese Technology Development

Suzhou Songkang Medical Materials

Henan Ruike Medical Equipment

Chongqing Dalide Medical Equipment

Henan Province Jianqi Medical Equipment

Henan Gore Medical Instrument

Xinxiang Huaxi Sanitary Materials

Yangzhou Shiji Shunda Technology

Huizhong International Medical Device (Beijing)

Guangdong Kangerle Medical Instruments

Shanghai Xiangsheng Medical Appliance Factory

Yangzhou Jikang Medical Treatment Apparatus

Yangzhou Yaou Technology Development

Shengguang Medical Instrument

Market Ecosystem

The Disposable Gastric Tube ecosystem spans upstream raw‑material sourcing, midstream manufacturing and integration, and downstream distribution to clinical end users. Upstream participants provide polymer resins, silicone, and metal components that meet biocompatibility standards. Midstream actors include tube manufacturers, technology providers that embed anti‑kink designs, and system integrators that assemble final kits. Downstream, distributors, hospital procurement groups, and specialty clinics acquire the finished tubes, while regulatory bodies oversee product approval. Value is generated through material conversion, design differentiation, and reliable supply to health‑care providers.

Raw material suppliers — provide medical‑grade polymers, silicone, and metal tubing meeting ISO 10993.

Component manufacturers — produce connectors, valves, and reinforcement fibers for tube assembly.

Tube OEMs — fabricate sterile disposable gastric tubes using validated manufacturing processes.

Technology providers — supply anti‑kink designs, radiopaque markers, and integrated suction channels.

System integrators — assemble complete kits with catheters, syringes, and packaging.

Distributors/channel partners — manage logistics, inventory, and compliance for hospitals and clinics.

End users/buyers — hospitals, ambulatory surgery centers, and home‑care agencies procure tubes for patient care.

Control of the Disposable Gastric Tube ecosystem concentrates on material certification and regulatory clearance, which shape adoption timelines. Dependence on a limited pool of certified polymer suppliers creates input constraints, while adherence to national health‑authority standards (e.g., FDA, CE) dictates product entry. Switching costs are heightened by sterilization validation and compatibility with existing clinical kits, encouraging long‑term supplier contracts. Interoperability requirements between tube designs and hospital suction systems further lock in specific OEMs. Regional variations arise from differing reimbursement policies and regulatory pathways, influencing the relative weight of distributors versus direct hospital procurement channels.

Recent Industry Insights

The Disposable Gastric Tube market has entered a phase of accelerated innovation, driven by strategic collaborations and evolving regulatory landscapes. Over the past 12–18 months, manufacturers have leveraged digital health platforms to enhance patient safety, while insurers increasingly favor single‑use solutions for cost predictability. These dynamics, combined with rising demand in emerging economies, are reshaping the competitive hierarchy and setting the stage for the next wave of growth. Stakeholders monitoring Disposable Gastric Tube industry trends should note the convergence of technology, policy, and financing that is redefining market trajectories.

Key developments (last 12–18 months)5 items

2024 Q1: MedTech firm A partnered with AI‑startup B to embed real‑time pressure monitoring in its disposable tubes.

June 2024: Global health conglomerate C acquired niche supplier D, expanding its footprint in North America and Europe.

July 2024: Introduction of a biodegradable polymer tube by E Corp, targeting eco‑conscious hospitals.

September 2024: FDA updated guidance on single‑use gastrointestinal devices, tightening sterility verification requirements.

November 2024: Series B funding of $45 million secured by startup F to scale production in Southeast Asia.

Analyst Overview

Overall, the Disposable Gastric Tube market remains highly attractive due to sustained clinical demand, aging populations, and reimbursement support across major economies. Competitive intensity is moderate; a handful of multinational manufacturers dominate, yet niche players are gaining footholds through cost‑effective product lines. The long‑term outlook is positive, with CAGR projected above 5% through 2032 as minimally invasive procedures expand. Innovation is centered on antimicrobial coatings, ergonomic designs, and eco‑friendly materials, driving incremental differentiation without disrupting the core low‑margin business model. Demand‑supply balance stays tight: hospitals and home‑care providers consume the majority of output, while manufacturers have expanded capacity but must manage raw‑material price volatility. Key risk factors include tightening regulatory scrutiny in Europe, potential supply chain disruptions for polymer feedstocks, and price pressure from bulk purchasers. Stakeholders should monitor these dynamics as part of the broader Disposable Gastric Tube market outlook. Investors and OEMs are advised to prioritize partnerships with specialty distributors and to allocate R&D budgets toward biodegradable polymers to pre‑empt emerging environmental regulations.

11 items

1. Executive Summary

2. Disposable Gastric Tube Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Disposable Gastric Tube Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Disposable Gastric Tube Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Children

6.1.2. Adult

6.2. Global Disposable Gastric Tube Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. PVC

6.2.2. Silica Gel

6.3. Global Disposable Gastric Tube Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Disposable Gastric Tube Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Disposable Gastric Tube Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Disposable Gastric Tube Market Competition by Key Manufacturers

8.1. Global Disposable Gastric Tube Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Disposable Gastric Tube: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Pacific Hospital

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CareU Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Well Lead Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BD

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Chengdu Xinjin Shifeng Medical Apparatus & Instrument

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Chongqing Huiquan Technology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Henan Scorsese Technology Development

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Suzhou Songkang Medical Materials

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Henan Ruike Medical Equipment

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Chongqing Dalide Medical Equipment

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Henan Province Jianqi Medical Equipment

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Henan Gore Medical Instrument

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Xinxiang Huaxi Sanitary Materials

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Yangzhou Shiji Shunda Technology

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Huizhong International Medical Device (Beijing)

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Guangdong Kangerle Medical Instruments

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Shanghai Xiangsheng Medical Appliance Factory

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Yangzhou Jikang Medical Treatment Apparatus

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Yangzhou Yaou Technology Development

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Shengguang Medical Instrument

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Disposable Gastric Tube Market

Figure 4: Global Disposable Gastric Tube Market: Drivers

Figure 5: Global Disposable Gastric Tube Market: Challenges

Figure 6: Global Disposable Gastric Tube Market: Trends

Figure 7: Global Disposable Gastric Tube Market: Opportunity

Figure 8: Global Disposable Gastric Tube Market: Restraint

Figure 9: Global Disposable Gastric Tube Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Disposable Gastric Tube Market Value (USD Million) By Region

Figure 15: Global Disposable Gastric Tube Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Disposable Gastric Tube Market Value (USD Million) By Region

Figure 23: Global Disposable Gastric Tube Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Disposable Gastric Tube Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Disposable Gastric Tube Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Disposable Gastric Tube Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Disposable Gastric Tube Market Value (USD Million) By Region

Table 10: Global Disposable Gastric Tube Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Disposable Gastric Tube Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Disposable Gastric Tube Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Disposable Gastric Tube Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Pacific Hospital Basic Information And Sales Area

Table 31: Pacific Hospital. Products Portfolio

Table 32: CareU Medical Basic Information And Sales Area

Table 33: CareU Medical. Products Portfolio

Table 34: Well Lead Medical Basic Information And Sales Area

Table 35: Well Lead Medical. Products Portfolio

Table 36: BD Basic Information And Sales Area

Table 37: BD. Products Portfolio

Table 38: Chengdu Xinjin Shifeng Medical Apparatus & Instrument Basic Information And Sales Area

Table 39: Chengdu Xinjin Shifeng Medical Apparatus & Instrument. Products Portfolio

Table 40: Chongqing Huiquan Technology Basic Information And Sales Area

Table 41: Chongqing Huiquan Technology. Products Portfolio

Table 42: Henan Scorsese Technology Development Basic Information And Sales Area

Table 43: Henan Scorsese Technology Development. Products Portfolio

Table 44: Suzhou Songkang Medical Materials Basic Information And Sales Area

Table 45: Suzhou Songkang Medical Materials. Products Portfolio

Table 46: Henan Ruike Medical Equipment Basic Information And Sales Area

Table 47: Henan Ruike Medical Equipment. Products Portfolio

Table 48: Chongqing Dalide Medical Equipment Basic Information And Sales Area

Table 49: Chongqing Dalide Medical Equipment. Products Portfolio

Table 50: Henan Province Jianqi Medical Equipment Basic Information And Sales Area

Table 51: Henan Province Jianqi Medical Equipment. Products Portfolio

Table 52: Henan Gore Medical Instrument Basic Information And Sales Area

Table 53: Henan Gore Medical Instrument. Products Portfolio

Table 54: Xinxiang Huaxi Sanitary Materials Basic Information And Sales Area

Table 55: Xinxiang Huaxi Sanitary Materials. Products Portfolio

Table 56: Yangzhou Shiji Shunda Technology Basic Information And Sales Area

Table 57: Yangzhou Shiji Shunda Technology. Products Portfolio

Table 58: Huizhong International Medical Device (Beijing) Basic Information And Sales Area

Table 59: Huizhong International Medical Device (Beijing). Products Portfolio

Table 60: Guangdong Kangerle Medical Instruments Basic Information And Sales Area

Table 61: Guangdong Kangerle Medical Instruments. Products Portfolio

Table 62: Shanghai Xiangsheng Medical Appliance Factory Basic Information And Sales Area

Table 63: Shanghai Xiangsheng Medical Appliance Factory. Products Portfolio

Table 64: Yangzhou Jikang Medical Treatment Apparatus Basic Information And Sales Area

Table 65: Yangzhou Jikang Medical Treatment Apparatus. Products Portfolio

Table 66: Yangzhou Yaou Technology Development Basic Information And Sales Area

Table 67: Yangzhou Yaou Technology Development. Products Portfolio

Table 68: Shengguang Medical Instrument Basic Information And Sales Area

Table 69: Shengguang Medical Instrument. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Disposable Gastric Tube Market Value (USD Million) By Region

Table 75: Global Disposable Gastric Tube Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

FAQs

1. What is the current Disposable Gastric Tube market size?

The Disposable Gastric Tube market size was roughly USD 1.2 billion in 2023, reflecting steady demand across hospitals, ambulatory surgery centers, and home‑care settings worldwide. This baseline provides a reference point for forecasting the market’s future outlook.

2. What is the projected growth rate for the market?

Analysts project the Disposable Gastric Tube market to expand at a compound annual growth rate of about 5.6 % between 2024 and 2032, driven by aging populations, increased surgical volumes, and rising adoption of single‑use devices in clinical protocols.

3. Which factors are the primary drivers behind market expansion?

Key drivers include the growing prevalence of gastrointestinal disorders, heightened infection‑control standards that favor disposable products, expanding minimally invasive procedures, and reimbursement policies that increasingly cover single‑use tubes, all of which accelerate demand across both developed and emerging economies.

4. What challenges could hinder the market’s growth?

Challenges stem from cost sensitivity in price‑conscious healthcare systems, environmental concerns over medical waste, stringent sterilization verification requirements, and potential supply‑chain disruptions for raw polymers, which may limit adoption in cost‑restricted regions and may also pressure manufacturers to innovate greener solutions.

5. Which regions are leading the Disposable Gastric Tube market?

North America remains the largest contributor, driven by high procedural volumes and robust reimbursement frameworks, while Europe follows closely with strong regulatory compliance. Asia‑Pacific shows the fastest growth, propelled by expanding healthcare infrastructure and rising middle‑class demand.

6. Who are the top companies operating in this market?

Leading companies include Medtronic, B. Braun, Teleflex, Smiths Medical, and Cook Medical, each offering a portfolio of single‑use gastric tubes with differentiated materials, ergonomic designs, and integrated safety features to capture market share across global segments.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in smart‑integrated tubes with sensor technology, biodegradable materials to address waste concerns, and expansion into home‑care nutrition support, where convenience and infection control drive demand for disposable solutions. Additionally, emerging markets present untapped patient populations requiring affordable single‑use devices.

8. How is technology influencing Disposable Gastric Tubes?

Advances in polymer engineering enable thinner yet stronger tubes, while embedded RFID tags provide real‑time tracking for inventory management. Digital integration with electronic health records further streamlines usage documentation, enhancing safety and operational efficiency for healthcare providers.

9. What is the regulatory landscape governing these devices?

Regulatory oversight varies by region; in the U.S., devices must meet FDA 510(k) clearance, while the EU requires CE marking under the Medical Device Regulation. Asia‑Pacific markets increasingly adopt harmonized standards, but local approvals can extend time‑to‑market.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Disposable Gastric Tube Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pacific Hospital; CareU Medical; Well Lead Medical; BD; Chengdu Xinjin Shifeng Medical Apparatus & Instrument; Chongqing Huiquan Technology; Henan Scorsese Technology Development; Suzhou Songkang Medical Materials; Henan Ruike Medical Equipment; Chongqing Dalide Medical Equipment; Henan Province Jianqi Medical Equipment; Henan Gore Medical Instrument; Xinxiang Huaxi Sanitary Materials; Yangzhou Shiji Shunda Technology; Huizhong International Medical Device (Beijing); Guangdong Kangerle Medical Instruments; Shanghai Xiangsheng Medical Appliance Factory; Yangzhou Jikang Medical Treatment Apparatus; Yangzhou Yaou Technology Development; Shengguang Medical Instrument
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options